Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.

Published on Mar 9, 2017in American Journal of Neuroradiology3.381
· DOI :10.3174/AJNR.A5099
A. Krishnan4
Estimated H-index: 4
,
Roshan Karunamuni15
Estimated H-index: 15
+ 13 AuthorsNathan S. White28
Estimated H-index: 28
Sources
Abstract
BACKGROUND AND PURPOSE: ADC as a marker of tumor cellularity has been promising for evaluating the response to therapy in patients with glioblastoma but does not successfully stratify patients according to outcomes, especially in the upfront setting. Here we investigate whether restriction spectrum imaging, an advanced diffusion imaging model, performed after an operation but before radiation therapy, could improve risk stratification in patients with newly diagnosed glioblastoma relative to ADC. MATERIALS AND METHODS: Pre-radiation therapy diffusion-weighted and structural imaging of 40 patients with glioblastoma were examined retrospectively. Restriction spectrum imaging and ADC-based hypercellularity volume fraction (restriction spectrum imaging–FLAIR volume fraction, restriction spectrum imaging–contrast-enhanced volume fraction, ADC-FLAIR volume fraction, ADC–contrast-enhanced volume fraction) and intensities (restriction spectrum imaging—FLAIR 90th percentile, restriction spectrum imaging–contrast-enhanced 90th percentile, ADC-FLAIR 10th percentile, ADC–contrast-enhanced 10th percentile) within the contrast-enhanced and FLAIR hyperintensity VOIs were calculated. The association of diffusion imaging metrics, contrast-enhanced volume, and FLAIR hyperintensity volume with progression-free survival and overall survival was evaluated by using Cox proportional hazards models. RESULTS: Among the diffusion metrics, restriction spectrum imaging–FLAIR volume fraction was the strongest prognostic metric of progression-free survival (P = .036) and overall survival (P = .007) in a multivariate Cox proportional hazards analysis, with higher values indicating earlier progression and shorter survival. Restriction spectrum imaging—FLAIR 90th percentile was also associated with overall survival (P = .043), with higher intensities, indicating shorter survival. None of the ADC metrics were associated with progression-free survival/overall survival. Contrast-enhanced volume exhibited a trend toward significance for overall survival (P = .063). CONCLUSIONS: Restriction spectrum imaging–derived cellularity in FLAIR hyperintensity regions may be a more robust prognostic marker than ADC and conventional imaging for early progression and poorer survival in patients with glioblastoma. However, future studies with larger samples are needed to explore its predictive ability.
📖 Papers frequently viewed together
25 Citations
2 Citations
64 Citations
References30
Newest
#1Carrie R. McDonaldH-Index: 38
#2Rachel L. DelfantiH-Index: 5
Last. Nikdokht FaridH-Index: 17
view all 14 authors...
Diffusion-weighted imaging has shown initial promise for evaluating response to bevacizumab in patients with high-grade glioma (HGG). However, it is well recognized that the apparent diffusion coefficient (ADC) is influenced by bevacizumab-induced reductions in edema, which may limit its prognostic value. We demonstrate that an advanced diffusion-weighted imaging technique, restriction spectrum imaging (RSI), improves the evaluation of response to bevacizumab because unlike ADC, RSI is not affec...
25 CitationsSource
#1Tuva R. Hope (NTNU: Norwegian University of Science and Technology)H-Index: 5
#2Nathan S. White (UCSD: University of California, San Diego)H-Index: 28
Last. Anders M. Dale (UCSD: University of California, San Diego)H-Index: 166
view all 13 authors...
The diffusion weighted imaging (DWI) technique enables quantification of water mobility for probing microstructural properties of biological tissue, and has become an effective tool for collecting information about the underlying pathology of cancerous tissue. Measurements using multiple b-values have indicated a bi-exponential signal attenuation, ascribed to “fast” (high ADC) and “slow” (low ADC) diffusion components. In this empirical study, we investigate the properties of the diffusion time ...
14 CitationsSource
#1Kevin C. McCammack (UCSD: University of California, San Diego)H-Index: 7
#2Christopher J. Kane (UCSD: University of California, San Diego)H-Index: 70
Last. David S. Karow (UCSD: University of California, San Diego)H-Index: 20
view all 18 authors...
Author(s): McCammack, KC; Kane, CJ; Parsons, JK; White, NS; Schenker-Ahmed, NM; Kuperman, JM; Bartsch, H; Desikan, RS; Rakow-Penner, RA; Adams, D; Liss, MA; Mattrey, RF; Bradley, WG; Margolis, DJA; Raman, SS; Shabaik, A; Dale, AM; Karow, DS | Abstract: © 2016 Macmillan Publishers Limited. Background:Magnetic resonance imaging (MRI) is emerging as a robust, noninvasive method for detecting and characterizing prostate cancer (PCa), but limitations remain in its ability to distinguish cancerous fro...
12 CitationsSource
#1Katherine L. Eales (University of Birmingham)H-Index: 6
#2Kate E.R. Hollinshead (University of Birmingham)H-Index: 7
Last. Daniel A. Tennant (University of Birmingham)H-Index: 25
view all 3 authors...
Low oxygen tension (hypoxia) is a pervasive physiological and pathophysiological stimulus that metazoan organisms have contended with since they evolved from their single-celled ancestors. The effect of hypoxia on a tissue can be either positive or negative, depending on the severity, duration and context. Over the long-term, hypoxia is not usually consistent with normal function and so multicellular organisms have had to evolve both systemic and cellular responses to hypoxia. Our reliance on ox...
358 CitationsSource
#1Qiuting Wen (UCSF: University of California, San Francisco)H-Index: 5
#2Laleh Jalilian (UCSF: University of California, San Francisco)H-Index: 1
Last. Sarah J. Nelson (UCSF: University of California, San Francisco)H-Index: 93
view all 8 authors...
To evaluate metrics that describe changes in apparent diffusion coefficient (ADC) and to examine their association with clinical outcome for patients with newly diagnosed GBM who were participating in a Phase II clinical trial of treatment with radiation (RT), temozolomide, erlatonib and bevacizumab. Thirty six patients were imaged after surgery but prior to therapy and at regular follow-up time points. The following ADC metrics were evaluated: (1) histogram percentiles within the T2-hyperintens...
30 CitationsSource
High-grade gliomas (HGGs) constitute ∼15% of all primary brain tumors in children and adolescents. Routine histopathological diagnosis is based on tissue obtained from biopsy or, preferably, from the resected tumor itself. The majority of pediatric HGGs are clinically and biologically distinct from histologically similar adult malignant gliomas; these differences may explain the disparate responses to therapy and clinical outcomes when comparing children and adults with HGG. The recently propose...
23 CitationsSource
#1Steven K. Carlsson (UM: University of Miami)H-Index: 2
#3Claes Wahlestedt (UM: University of Miami)H-Index: 94
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique treatment limitations such as the high average age of onset, tumor location, and poor current understandings of the tumor pathophysiology. The resection techniques, chemotherapic strategies, and radiation therapy currently used to treat GBM have slowly evolved, but the improvements have not translated to marked increase...
166 CitationsSource
#1Nathan S. White (UCSD: University of California, San Diego)H-Index: 28
#2Anders M. DaleH-Index: 166
Purpose While many recent studies have demonstrated improved detection and characterization of malignant lesions using high b-value diffusion imaging techniques, little is known about the underlying physical characteristics of tumor cells that modulate the restricted water signal at high b on clinical scanners. Methods Monte Carlo simulations of diffusion in a synthetic tumor cell environment were used to study the specific effects of tumor cell diameter and nuclear volume fraction (ν) on high b...
27 CitationsSource
#2Solmaz Sahebjam (U of T: University of Toronto)H-Index: 16
Last. Timothy F. Cloughesy (UCLA: University of California, Los Angeles)H-Index: 120
view all 10 authors...
BACKGROUND AND PURPOSE: Pre-treatment ADC characteristics have been shown to predict response to bevacizumab in recurrent glioblastoma multiforme. However, no studies have examined whether ADC characteristics are specific to this particular treatment. The purpose of the current study was to determine whether ADC histogram analysis is a bevacizumab-specific or treatment-independent biomarker of treatment response in recurrent glioblastoma multiforme. MATERIALS AND METHODS: Eighty-nine bevacizumab...
49 CitationsSource
#1Yan Li (UCSF: University of California, San Francisco)H-Index: 15
#2Janine M. LupoH-Index: 25
Last. Sarah J. NelsonH-Index: 93
view all 7 authors...
Glioblastoma multiforme (GBM) is the most common and most malignant type of glioma. Despite advances in multimodal treatments that combine surgery, radiation therapy (RT), and chemotherapy, patients with GBM have a limited prognosis, with a median survival of 15 months.1 Conventional MRI can delineate structural abnormalities such as regions where the blood–brain barrier has been compromised, but it fails to distinguish among edema, gliosis, inflammation, and active tumor. The Macdonald criteria...
48 CitationsSource
Cited By6
Newest
#1Christopher Farrell (Thomas Jefferson University)H-Index: 19
#2Wenyin Shi (Thomas Jefferson University)H-Index: 24
Last. Jeffrey J. Olson (Emory University)H-Index: 68
view all 4 authors...
These recommendations apply to adult patients with newly diagnosed or suspected glioblastoma. Question What imaging modalities are in development that may be able to provide improvements in diagnosis, and therapeutic guidance for individuals with newly diagnosed glioblastoma? Level III: It is suggested that techniques utilizing magnetic resonance imaging for diffusion weighted imaging, and to measure cerebral blood and magnetic spectroscopic resonance imaging of N-acetyl aspartate, choline and t...
3 CitationsSource
#1Anna Latysheva (Oslo University Hospital)H-Index: 3
#2Oliver Geier (Oslo University Hospital)H-Index: 16
Last. Andres Server (Oslo University Hospital)H-Index: 20
view all 8 authors...
PURPOSE We studied the ability of Restriction Spectrum Imaging (RSI), a novel advanced diffusion imaging technique, to estimate levels of cellularity in different glioblastoma regions, evaluated their prognostic value compared with established clinical diffusion metrics such as fractional anisotropy (FA) and mean diffusivity (MD). METHODS Forty-two patients with untreated glioblastoma, IDH-wildtype, were examined with an advanced MRI tumor protocol. The region of interest (ROI) was obtained from...
2 CitationsSource
#1Seyed Ali Nabavizadeh (UPenn: University of Pennsylvania)H-Index: 11
#2Jeffrey B. WareH-Index: 9
Last. Ronald L. WolfH-Index: 36
view all 3 authors...
Magnetic resonance imaging (MRI) has been the cornerstone of imaging of brain tumors in the past 4 decades. Conventional MRI remains the workhorse for neuro-oncologic imaging, not only for basic information such as location, extent, and navigation but also able to provide information regarding proliferation and infiltration, angiogenesis, hemorrhage, and more. More sophisticated MRI sequences have extended the ability to assess and quantify these features; for example, permeability and perfusion...
1 CitationsSource
#1Usman Khan (UCSD: University of California, San Diego)H-Index: 16
#1Usman A. Khan (UCSD: University of California, San Diego)H-Index: 42
Last. Clark C. Chen (UMN: University of Minnesota)H-Index: 56
view all 7 authors...
Abstract Discriminating between tumor recurrence and treatment effects in glioblastoma patients undergoing radiation-temozolomide (RT/TMZ) therapy remains a major clinical challenge. Here, we report a pilot study to determine the utility of restriction spectrum imaging (RSI), an advanced diffusion-weighted MRI (DWI) technique that affords meso-scale resolution of cell density, in this assessment. A retrospective review of 31 patients with glioblastoma treated between 2011 and 2017 who underwent ...
6 CitationsSource
#1Whitney B. Pope (UCLA: University of California, Los Angeles)H-Index: 62
#2Garth Brandal (UCLA: University of California, Los Angeles)H-Index: 1
: Magnetic resonance imaging is integral to the care of patients with high-grade gliomas. Anatomic detail can be acquired with conventional structural imaging, but newer approaches also add capabilities to interrogate image-derived physiologic and molecular characteristics of central nervous system neoplasms. These advanced imaging techniques are increasingly employed to generate biomarkers that better reflect tumor burden and therapy response. The following is an overview of current strategies ...
30 CitationsSource
#1Hari Nandu (Brigham and Women's Hospital)H-Index: 1
#2Patrick Y. Wen (Harvard University)H-Index: 118
Last. Raymond Y. Huang (Brigham and Women's Hospital)H-Index: 29
view all 3 authors...
Imaging plays several key roles in managing brain tumors, including diagnosis, prognosis, and treatment response assessment. Ongoing challenges remain as new therapies emerge and there are urgent needs to find accurate and clinically feasible methods to noninvasively evaluate brain tumors before and after treatment. This review aims to provide an overview of several advanced imaging modalities including magnetic resonance imaging and positron emission tomography (PET), including advances in new ...
24 CitationsSource